Subscribe to Newsletter
Business & Regulation Standards & Regulation

Amazon’s FDA Warning Letters

Last year, a relative bought me a counterfeit box set for Christmas. When I mentioned it was counterfeit, they were surprised because they had purchased it from Amazon. What they perhaps didn’t know is that the online retail giant has a huge problem with counterfeit goods; Amazon’s own 2021 Brand Protection Report revealed that the company identified more than 3 million counterfeit products in 2021, and sued or referred for investigation over 600 criminals. It’s also spending big bucks to address the problem – $900 million and 12,000 people have been thrown at the issues of counterfeits, fraud, and other forms of abuse.

Though counterfeit box sets are unlikely to harm human health, counterfeit medicines are a different story. And the FDA has now turned its critical eye on Jeff Bezos’ e-commerce empire.

In August, received an FDA Warning Letter for selling products for mole and skin tag removal. Though the products were distributed by Amazon on behalf of third parties, the FDA says that Amazon is still responsible. Notably, there are currently no OTC products approved for these indications. has now received a second FDA Warning Letter. This time, the FDA tested dietary supplements and found traces of diclofenac – an NSAID associated with the risk of increased cardiovascular events, including heart attack. The specific products mentioned were “Artri Ajo King,” “Artri King Reforzado con Ortiga y Omega 3,” and “Ortiga Mas Ajo Rey.”

Products marketed with the names “Artri” and “Ortiga” were highlighted in an FDA warning to consumers in April 2022, when the agency found the presence of APIs not listed on the product labels, including diclofenac, dexamethasone, and methocarbamol. It’s possible that ingredients would also vary from lot to lot. A warning for Artri Ajo King products was also issued in January 2022 – and, since then, the FDA has received adverse event reports, including liver toxicity and death, associated with the use the products. The FDA says, “Health care professionals should evaluate patients who have used Artri and Ortiga products for drug and disease interactions involving diclofenac, methocarbamol, and corticosteroids, and treat accordingly.”

The latest warning letter to likely stems from the FDA’s ongoing investigation into the distribution of these products in the US. seems to have taken swift action – I was unable to find any of these products when searching.

But, given the scale of the retailer’s presence – and the size of its counterfeit problem – it seems unlikely that this will be the last time runs afoul of the FDA.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Stephanie Sutton

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine